fair value 23c ready for 400% up, page-38

Hi BT,

"In the short term, the critical success factor for NuSep is achieving regulatory approval post the first clinical trial of a therapeutic plasma product using the PrIME Technology."

I believe ABS Novacell have done their DD, otherwise we wont see the proposal. so regulatory approval should be no problem.

I think once the approval announced, SP should be soar to 10c-15c range. If the $15m funding for 30% of PriME finalized, NSP cashed up, SP should be 20c-26c supported by the funding and proposal to establish a franchise plasm fractionation facility in India from ABS Novacell.

I am happy with the progress NSP made so far, and appreciate the positive news flow recently.

My comments and prediction are all based on the company announcements not like sb based on pure emotion.

Hopefully, the news from Chinese investor will come soon and that's why I believe SP 35c is achievable.